{"id":"W2321034066","doi":"10.1097/01.cot.0000416570.49020.3e","title":"Best of ASCO 2012","year":2012,"lang":"en","type":"article","venue":"Oncology Times","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Carfilzomib; Medicine; Lenalidomide; Multiple myeloma; Tolerability; Internal medicine; Thalidomide; Oncology; Plasma cell leukemia; Dexamethasone; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001698986,0.00006142436,0.0002095524,0.00004722632,0.00002275367,0.000001014667,0.00003834871,0.00008416764,0.003158251],"category_scores_gemma":[0.0001094269,0.00004479636,0.00005018116,0.00005902513,0.00009523131,0.00007120782,0.00003195433,0.00008386684,0.001272012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001143287,"about_ca_system_score_gemma":0.0002008355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000663791,"about_ca_topic_score_gemma":0.000009519297,"domain_scores_codex":[0.9993521,0.00003997747,0.0001090234,0.00007218123,0.0001565362,0.000270212],"domain_scores_gemma":[0.9994489,0.0001019466,0.00003709105,0.0001499511,0.00006891508,0.0001931768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006036539,0.003384523,0.7753875,0.00007785758,0.0004338921,0.00008427327,0.0004164902,2.048591e-7,0.008024265,0.001198678,0.07630791,0.1340807],"study_design_scores_gemma":[0.004525735,0.00209098,0.3795215,0.00004128209,0.000178941,0.0001790466,0.0001352866,0.0000235721,0.0142705,0.00007179308,0.5988685,0.00009281367],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.4483303,0.003697417,0.00001443311,0.001161398,0.0001575777,0.0002591538,0.00000842221,0.00002231309,0.546349],"genre_scores_gemma":[0.9416642,0.00009151422,0.002187998,0.000085475,0.0001552545,0.00001805872,0.00001340866,0.000008259995,0.05577581],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5225606,"threshold_uncertainty_score":0.9995056,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04620166454705379,"score_gpt":0.3837018831152496,"score_spread":0.3375002185681958,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}